Organogenesis Holdings Inc.
Pharmaceutical company · Canton, Massachusetts, United States · Nasdaq: ORGO
Organogenesis Holdings Inc. is a pharmaceutical company headquartered in Canton, Massachusetts, United States. Its shares trade on Nasdaq under the ticker ORGO. It has reported private securities offerings to the US SEC, most recently $130 million sold in a notice filed in 2024.
Organogenesis Holdings at a glance
What does Organogenesis Holdings do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $130 million sold (2024).
Frequently asked questions about Organogenesis Holdings
Where is Organogenesis Holdings headquartered?
Organogenesis Holdings Inc. is headquartered in Canton, Massachusetts, United States.
What does Organogenesis Holdings do?
Organogenesis Holdings Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Organogenesis Holdings a public company?
Yes. Organogenesis Holdings Inc. trades on Nasdaq under the ticker ORGO.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences